AI-powered multi-omics platform for breakthrough genetic insights
Sequegenics has raised $500K in total funding. The most recent round was Pre-Seed. The last funding was announced in August 2023.
Sequegenics's investors include National Science Foundation, Right Side Capital Management, BioTools Innovator, Georgia Research Alliance.
Sequegenics is headquartered in Atlanta, United States.
AI-powered multi-omics platform for breakthrough genetic insights
Sequegenics is at the Pre-Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Sequegenics — Funding & Investors." VCBacked, August 3, 2023, https://www.vcbacked.co/company/sequegenics. Accessed July 19, 2026.
VCBacked. (2023). Sequegenics — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/sequegenics
{{cite web |title=Sequegenics — Funding & Investors |url=https://www.vcbacked.co/company/sequegenics |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated